Efficacy of switching to dolutegravir plus rilpivirine, the small-tablet regimen, in patients with dysphagia: two case reports
Abstract Background The advent of well-tolerated and effective anti-retroviral drugs against human immunodeficiency virus-1 (HIV-1) infection has been a major step forward that has achieved long-term survival in recent years. The number of HIV-1 infected patients who experience difficulty in swallow...
Saved in:
Main Authors: | Takefumi Suzuki (Author), Nobuko Hara (Author), Morichika Osa (Author), Kazuhisa Misawa (Author), Kazuo Imai (Author), Yuji Fujikura (Author), Takuya Maeda (Author), Wataru Sonehara (Author), Akihiko Kawana (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2017-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination Tablet
by: Mehta R, et al.
Published: (2020) -
Development and Validation of RP-HPLC Method for the Estimation of Dolutegravir and Rilpivirine in Bulk and its Tablet Dosage form
by: P Pravalika, et al.
Published: (2021) -
The role of rilpivirine in Southern Africa
by: Michelle A. Moorhouse, et al.
Published: (2019) -
Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir
by: Supphachoke Khemla, et al.
Published: (2023) -
Experiences to date with the logistical management of long-acting cabotegravir and rilpivirine
by: Kamile Johnson, et al.
Published: (2022)